ArQule | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
399	14	0	ARQL

Emcee: noronha	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
374	- ArQule Appoints Dr. Philippe Bey, Formerly of Hoechst Marion Roussel (HMR), a	NJ Investors	-	8/2/1999
373	Hogan exercises options at 27, drives company into ground, and splits, pursuing	scaram(o)uche	-	8/2/1999
372	You wrote: Even if the SEPR patent is bogus, who is going to fight it? _____	John Dwyer	-	7/28/1999
371	<<My point with the patent issue is that SEPR is developing an improved v	tommysdad	-	7/28/1999
370	You wrote: So I did a little comparison of ARQL and SEPR. SEPR has a p/s of 15	John Dwyer	-	7/28/1999
369	<Also, despite the admonitions, one of the drug design companies could do as	LLCF	-	7/28/1999
368	Look, I just don't want to hear another "butt" analogy from Rick,	John Dwyer	-	7/28/1999
367	It appears I have gotten into a nest of SEPR lovers on this thread. I did the	Herc	-	7/28/1999
366	The reason that I'm attracted to these drug design companies is that most	Herc	-	7/28/1999
365	Herc, There's good reason you encountered so much cynicism about Arqule. I	rkrw	-	7/28/1999
364	"jumping all over"? Well, I'll stand by my statement that SEPR a	tommysdad	-	7/28/1999
363	I put my vote for ABSC. I have not researched CCHM. PCOP and TRGA are somewh	Biotech Jim	-	7/27/1999
362	I have no idea why you guys are jumping all over Herc. A little fresh blood on	John Dwyer	-	7/27/1999
361	Other than ARQL, which of the following do you like the best? ABSC BCRX CCHM P	Herc	-	7/27/1999
360	Calling ARQL an embryonic SEPR is far-fetched in the extreme. The business mod	tommysdad	-	7/27/1999
359	I live a couple miles from ARQL and pass by when I go to Costco... The same ra	Pierre Borczuk	-	7/27/1999
358	Upon reviewing the investor info. packet the company sent me, it is true that A	Herc	-	7/26/1999
357	For long time investors, would you reflect on the changes in ARQL and this segm	NJ Investors	-	7/23/1999
356	I used to own ArQule. I'm watching the company to keep in touch on the pr	John Metcalf	-	7/22/1999
355	Now that I think about it, everyone who responded to my queries seemed to jump	Herc	-	7/22/1999
354	Thanks for the input. That's the reason for SI--exchanging information.	Herc	-	7/22/1999
353	<<ARQL and SEPR both design molecules for the drug industry. What other c	tommysdad	-	7/22/1999
352	Herc, The Pfizer deal is non-royalty bearing. That's very non-Sepracor l	rkrw	-	7/22/1999
351	<i>I am saying that ARQL could be an embryonic SEPR.</i> And I <	JZGalt	-	7/22/1999
350	ARQL and SEPR both design molecules for the drug industry. What other companie	Herc	-	7/22/1999

Go to reply# or date (mm/dd/yy):